Clinical trial
Combination Chemotherapy in Treating Patients With Multiple Myeloma
NCT00002678 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00002678 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Multiple Myeloma |
| Official title | Comparative Study of Dexamethasone vs Prednisone (Both in Combination With Melphalan) as Induction Therapy in Untreated Symptomatic Myeloma With an Additional Assessment of Dexamethasone vs no Additional Treatment as Maintenance Therapy in Non-Progressing Patients |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Drug |
| Interventions | dexamethasone, melphalan, prednisone |
| Enrollment | 595 |
| Start date | Jun 2, 1995 |
| Primary completion | May 3, 2004 |
| Completion | Dec 21, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 2, 2020 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: